cgp 42112a has been researched along with captopril in 5 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (captopril) | Trials (captopril) | Recent Studies (post-2010) (captopril) |
---|---|---|---|---|---|
233 | 0 | 35 | 10,320 | 1,514 | 890 |
Protein | Taxonomy | cgp 42112a (IC50) | captopril (IC50) |
---|---|---|---|
Leukotriene A-4 hydrolase | Homo sapiens (human) | 3.6 | |
Angiotensin-converting enzyme | Homo sapiens (human) | 0.084 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0173 | |
Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | 3.3 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.1004 | |
Beta-lactamase | Pseudomonas aeruginosa | 5 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.011 | |
Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | 3.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campan, M; Costerousse, O; Desgranges, C; Gadeau, AP; Millet, D | 1 |
Heininger, F; Phillips, MI; Toffolo, S | 1 |
Arendshorst, WJ; Coffman, TM; Oliverio, MI; Ruan, X | 1 |
Fabiani, ME; Frauman, AG; Johnston, CI; Sourial, M; Thomas, WG | 1 |
Ager, EI; Chan, J; Chong, WW; Christophi, C; Neo, JH; Wen, SW | 1 |
5 other study(ies) available for cgp 42112a and captopril
Article | Year |
---|---|
Effects of angiotensins on cellular hypertrophy and c-fos expression in cultured arterial smooth muscle cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Biphenyl Compounds; Captopril; Cells, Cultured; DNA; Imidazoles; Indoles; Losartan; Muscle, Smooth, Vascular; Oligopeptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred WKY; RNA; Tetrazoles | 1992 |
The role of brain angiotensin in thirst and AVP release induced by hemorrhage.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Blood Volume; Captopril; Cohort Studies; Colony-Stimulating Factors; Drinking; Hemorrhage; Hypothalamus; Imidazoles; Injections, Intraperitoneal; Injections, Intraventricular; Losartan; Male; Oligopeptides; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Recombinant Proteins; Tetrazoles; Thirst; Time Factors; Vasopressins | 1996 |
Renal vascular reactivity in mice: AngII-induced vasoconstriction in AT1A receptor null mice.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Female; Imidazoles; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Circulation; Renin; Vasoconstriction | 1999 |
Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Norepinephrine; Oligopeptides; Prostate; Prostatic Hyperplasia; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sympathetic Nervous System; Synaptic Transmission | 2001 |
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Topics: Adenocarcinoma; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers, Tumor; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Irbesartan; Liver Neoplasms, Experimental; Mice; Mice, Inbred CBA; Molecular Targeted Therapy; Neoplasm Proteins; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A | 2011 |